Coping with fluid restriction and the quality of life in hemodialysis patients with very low or no daily urine output

Carregando...
Imagem de Miniatura
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
WICHTIG EDITORE
Autores
SILVA, Luciana F.
LOPES, Gildete B.
CUNHA, Taline O.
PISONI, Ronald L.
JAMES, Sherman A.
LOPES, Antonio A.
Citação
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, v.37, n.6, p.427-435, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Purpose: Fluid restriction is crucial to prevent circulatory overload in maintenance hemodialysis (MHD) patients with very low urine volume, but fluid restriction may result in psychological distress. We studied MHD patients with urine volume <= 200 ml/day to investigate if their acceptance of fluid restriction was associated with their health-related quality of life (HRQOL). Methods: Cross-sectional study of 271 Brazilian adult MHD patients enrolled in the Prospective Study of the Prognosis of Chronic Hemodialysis Patients (PROHEMO). To assess the acceptance of fluid restriction, patients were asked about the extent of feeling bothered by living on this restriction. The KDQOL was used to determine HRQOL scores. Higher scores indicate better HRQOL with differences of >3.0 points considered clinically significant. Results: 52.4% reported being ""moderately to extremely"" bothered by fluid restriction and had lower scores for all HRQOL scales than patients less bothered by fluid restriction. The largest covariate-adjusted differences in HRQOL were 19.5 for emotional role (p<0.001), 15.1 for emotional well-being (p<0.001), and 14.1 for vitality (p<0.001). Adjusted differences were larger for mental component (7.53 points, p<0.001) than for physical component (2.07, p = 0.075) summaries. Conclusions: These results indicate that MHD patients with a lower level of acceptance of fluid restriction have poorer HRQOL, particularly in mental domains of HRQOL. The high prevalence of poor acceptance of fluid restriction in the present study underscores the need for interventions to improve acceptance of fluid restriction and determine if such interventions improve HRQOL of MHD patients with very low urine volume.
Palavras-chave
Fluid restriction, End-stage renal disease, Quality of life, Chronic dialysis, Treatment acceptance
Referências
  1. Bossola M, 2012, NAT REV NEPHROL, V8, P176, DOI 10.1038/nrneph.2011.218
  2. Bots CP, 2005, NEPHROL DIAL TRANSPL, V20, P578, DOI 10.1093/ndt/gfh675
  3. Bots CP, 2004, KIDNEY INT, V66, P1662, DOI 10.1111/j.1523-1755.2004.00933.x
  4. Branch WT, 2006, J GEN INTERN MED, V21, P1203, DOI 10.1111/j.1525-1497.2006.00572.x
  5. Cukor D, 2014, J AM SOC NEPHROL, V25, P196, DOI 10.1681/ASN.2012111134
  6. DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205
  7. Denhaerynck K, 2007, AM J CRIT CARE, V16, P236
  8. Denhaerynd K, 2007, AM J CRIT CARE, V16, P222
  9. Duarte PS, 2005, BRAZ J MED BIOL RES, V38, P261, DOI 10.1590/S0100-879X2005000200015
  10. Elander J, 2013, EUR J PAIN, V17, P929, DOI 10.1002/j.1532-2149.2012.00258.x
  11. Fan WF, 2013, KIDNEY BLOOD PRESS R, V37, P464, DOI 10.1159/000355717
  12. Fukuhara S, 2003, KIDNEY INT, V64, P1903, DOI 10.1046/j.1523-1755.2003.00289.x
  13. Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305
  14. HAYS RD, 1994, QUAL LIFE RES, V3, P329, DOI 10.1007/BF00451725
  15. Keogh A M, 1999, ANNA J, V26, P471
  16. Keogh AM, 1999, ANNA J, V26, P500
  17. Keogh AM, 1999, ANNA J, V26, P478
  18. Keogh AM, 1999, ANNA J, V26, P505
  19. Kimmel PL, 2000, KIDNEY INT, V57, P1141, DOI 10.1046/j.1523-1755.2000.00941.x
  20. Kurpas D, 2013, RESP PHYSIOL NEUROBI, V187, P114, DOI 10.1016/j.resp.2013.02.009
  21. Lewko J, 2012, SAUDI MED J, V33, P887
  22. Lopes AA, 2007, QUAL LIFE RES, V16, P545, DOI 10.1007/s11136-006-9143-7
  23. Lopes GB, 2010, NEPHRON CLIN PRACT, V115, pE35, DOI 10.1159/000286348
  24. Lopez-Gomez JM, 2005, KIDNEY INT, V67, pS63, DOI 10.1111/j.1523-1755.2005.09314.x
  25. Poppe C, 2013, NEPHROL DIAL TRANSPL, V28, P116, DOI 10.1093/ndt/gfs151
  26. Porcu M, 2007, J Ren Care, V33, P179
  27. Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165/00019053-199915020-00003
  28. Sezer S, 2002, RENAL FAILURE, V24, P37, DOI 10.1081/JDI-120002659
  29. Sharp J, 2005, AM J KIDNEY DIS, V45, P1046, DOI 10.1053/j.ajkd.2005.02.032
  30. Silva LF, 2011, J RENAL NUTR, V21, P235, DOI 10.1053/j.jrn.2010.07.004
  31. Termorshuizen F, 2004, J AM SOC NEPHROL, V15, P1061, DOI 10.1097/01.ASN.0000117976.29592.93
  32. Wang VV, 2012, INT J ARTIF ORGANS, V35, P217, DOI 10.5301/ijao.5000014
  33. Ware J. E., 1994, SF 36 PHYS MENTAL HL
  34. Yang LY, 2010, KIDNEY BLOOD PRESS R, V33, P260, DOI 10.1159/000317933
  35. Zhang TL, 2013, CHINESE MED J-PEKING, V126, P4124, DOI 10.3760/cma.j.issn.0366-6999.20131160